ReviewNature reviews. Endocrinology2026
Links between bone fractures and the gut microbiota.
Review in Nature reviews. Endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As populations age worldwide, the incidence of fractures is increasing, leading to considerable disease burden and increased health-care costs. Bone mineral density (BMD), bone quality and muscle function are major contributors to fracture risk, with muscle function having a critical role in preventing falls. The gut microbiota is well established as a regulator of these parameters in rodents, with the immune system and short-chain fatty acids acting as key mediators of these effects. First-generation probiotic interventions have demonstrated modest effects on BMD in clinical trials. In humans, the association between the gut microbiota and muscle mass, muscle function and fracture risk seems to be more robust than the correlation between gut microbiota and BMD. Future research should prioritize the development of more targeted gut microbiota-based interventions, including second-generation probiotics, personalized dietary strategies, synbiotics, postbiotics and species-specific antibiotics with the potential to enhance both BMD and muscle function, thereby reducing risk of fractures.
Identifiers
42533136What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.